Join the Hepatitis B group to help and get support from people like you.
Hepatitis B News
Related terms: Chronic Hepatitis B, Hepatitis B, Chronic, HBV
Chronic Hepatitis B Virus Is Undertreated
FRIDAY, May 3, 2024 – Underassessment and undertreatment of chronic hepatitis B virus (HBV) is seen globally, according to a study published online May 1 in the Journal of Hepatology. Sahith ...
Prevalence of Hepatitis Delta High in Hepatitis B Surface Antigen Chronic Carriers
THURSDAY, April 4, 2024 – The prevalence of hepatitis delta virus (HDV) is high in hepatitis B surface antigen (HBs Ag) chronic carriers detected through annual screenings, according to a study...
FDA Expands Indication for Gilead's Vemlidy (tenofovir alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
March 28, 2024 – FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug...
Antivirals Aid HBeAg-Negative Chronic Hepatitis B Patients
WEDNESDAY, Jan. 3, 2024 – Continuous nucleos(t)ide analog treatment is effective in lowering the risk for liver cirrhosis in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients, ...
Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
MONDAY, Sept. 18, 2023 – Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication,...
People Infected With Hepatitis C May Need the Hepatitis B Shot
MONDAY, Sept. 11, 2023 – Patients with hepatitis C should consider being vaccinated again for hepatitis B, because their immune response to the initial shot may be inadequate, a new study suggests....
ACOG Guideline Addresses Hepatitis in Pregnancy
TUESDAY, Aug. 22, 2023 – In a clinical practice guideline issued by the American College of Obstetricians and Gynecologists and published online Aug. 17 in Obstetrics & Gynecology, recommendations...
Recommendations Developed for Management of Acute Liver Failure
WEDNESDAY, July 12, 2023 – In a clinical guideline issued by the American College of Gastroenterology and published in the July issue of the American Journal of Gastroenterology, recommendations are...
Learn the Differences Between Hepatitis A, B, C, D & E
THURSDAY, July 6, 2023 – Curious about what the differences are between hepatitis A, B, C, D and E? If so, you’ve come to the right place. Here, experts break down hepatitis infection by type to r...
Hepatitis C Treatments: A Comprehensive Guide
THURSDAY, July 6, 2023 – Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly...
Need Accurate Info on Liver Disease? Don't Head to TikTok
TUESDAY, May 9, 2023 – About 4.5 million adults in the United States have liver disease. If they're looking for information about their condition, they'd be wise to look beyond TikTok, new research...
U.S. Food and Drug Administration Approves Vemlidy (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients
Approval Expands on Previous FDA Approval of Vemlidy in Adults Living With This Chronic Liver Disease Efficacy and Safety of Once-Daily Vemlidy Demonstrated in Individuals 12 Years of Age and Older ...
Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults
BERKELEY, CA – (Marketwired) – November 9, 2017 – Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B...
FDA Approves Gilead’s Vemlidy (tenofovir alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 10, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy (tenofovir...
FDA Medwatch Alert: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating
ISSUE: The FDA is warning about the risk of hepatitis B virus (HBV) becoming an active infection again in any patient who has a current or previous infection with HBV and is treated with certain...
Ask a question
To post your own question to this support group, sign in or create an account.